The document is an intimation of an earnings conference call for discussion of Q2 FY26 financial results.
The event is scheduled for 6:30 PM IST on Friday, 30 October 2026 and will be one hour long.
The purpose is for senior management to discuss the company's Q2 performance and answer participant questions.
The earnings results will be announced on the same day (30 October 2026) before the call.
Management participants are referred to as "senior management" but no specific names or designations are provided.
The conference call will be available via telephone numbers (+91 22 6629 0049, +91 22 7194 5729) and audio webcast (details to be announced on website).
A transcript of the conference call will be made available on the company website www.sunpharma.com.
The document contains standard forward-looking statement disclaimer language but does not explicitly state whether unpublished price sensitive information (UPSI) will be shared.
Additional Notes Section
The document is a press release format intimation addressed to stock exchanges.
No financial data, guidance references, or presentation summaries are included in this announcement.
Pre-registration is recommended via DiamondPassRegistration link to avoid wait time.
Contact information for investor relations personnel (Dr. Abhishek Sharma and Gaurav Chugh) is provided.
